G Trifan, N Shafi, FD Testai - Journal of Stroke and Cerebrovascular …, 2018 - Elsevier
The role of genetic mutations in cerebral ischemia is not completely understood. Among these genetic variations, Philadelphia-negative gain-of-function mutation in the janus kinase …
M Abdelghani, H Hammami, W Zidi… - Journal of Clinical …, 2022 - Wiley Online Library
Background The genetic investigation of essential thrombocythemia (ET) has highlighted the presence of driver mutations in ET. Janus kinase JAK2V617F and calreticulin (CALR) …
E Ümit, M Baysal, HO Kırkızlar… - Turkish Journal of …, 2024 - jag.journalagent.com
Abstract Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN- SAF TSS) is a surrogate marker for symptom evaluation in Chronic Myeloproliferative …
K Singh, V Pradeep, A Ahuja… - Journal of …, 2022 - thieme-connect.com
Objective Philadelphia-negative chronic myeloproliferative neoplasms (CMPNs), which include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis …
HP Pati, P Sharma - Indian Journal of Hematology and Blood Transfusion, 2016 - Springer
In the current issue of IJHBT, Uyanik et al.[1] present data from 101 patients with essential thrombocythemia (ET) and polycythemia vera (PV) with reference to the development of …